The enantiomers of many chiral drugs not only exhibit different pharmacological effects in regard to targets that dictate therapeutic and toxic effects, but are also handled differently in the body du
Enterally-administered nimodipine is the only approved drug formulation available in the United States for treatment of patients with aneurysmal subarachnoid hemorrhage. Intravenous nimodipine is avai
IV: intravenous. SC: subcutaneous. AUC0–24h: area under the plasma drug concentration-time curve between 0 to 24 hours. n.s.s: non statistically significant. Cmax: maximum concentration. tmax: time to
